These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31324811)

  • 21. Self-Strengthened Oxidation-Responsive Bioactivating Prodrug Nanosystem with Sequential and Synergistically Facilitated Drug Release for Treatment of Breast Cancer.
    Wang K; Yang B; Ye H; Zhang X; Song H; Wang X; Li N; Wei L; Wang Y; Zhang H; Kan Q; He Z; Wang D; Sun J
    ACS Appl Mater Interfaces; 2019 May; 11(21):18914-18922. PubMed ID: 31055911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small changes in the length of diselenide bond-containing linkages exert great influences on the antitumor activity of docetaxel homodimeric prodrug nanoassemblies.
    Li L; Zuo S; Dong F; Liu T; Gao Y; Yang Y; Wang X; Sun J; Sun B; He Z
    Asian J Pharm Sci; 2021 May; 16(3):337-349. PubMed ID: 34276822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zein-Paclitaxel Prodrug Nanoparticles for Redox-Triggered Drug Delivery and Enhanced Therapeutic Efficiency.
    Hou H; Zhang D; Lin J; Zhang Y; Li C; Wang Z; Ren J; Yao M; Wong KH; Wang Y
    J Agric Food Chem; 2018 Nov; 66(44):11812-11822. PubMed ID: 30339011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rational Engineering Docetaxel Prodrug Nanoassemblies: Response Modules Guiding Efficacy Enhancement and Toxicity Reduction.
    Wang D; Li L; Xu H; Sun Y; Li W; Liu T; Li Y; Shi X; He Z; Zhai Y; Sun B; Sun J
    Nano Lett; 2023 Apr; 23(8):3549-3557. PubMed ID: 37053460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
    Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
    Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Redox responsive paclitaxel dimer for programmed drug release and selectively killing cancer cells.
    Xia R; Pei Q; Wang J; Wang Z; Hu X; Xie Z
    J Colloid Interface Sci; 2020 Nov; 580():785-793. PubMed ID: 32721635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction-responsive amphiphilic polymeric prodrugs of camptothecin-polyphosphoester for cancer chemotherapy.
    Jin H; Sun M; Shi L; Zhu X; Huang W; Yan D
    Biomater Sci; 2018 May; 6(6):1403-1413. PubMed ID: 29595843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triglyceride-Mimetic Structure-Gated Prodrug Nanoparticles for Smart Cancer Therapy.
    Tian C; Guo J; Miao Y; Zheng S; Sun B; Sun M; Ye Q; Liu W; Zhou S; Kamei KI; He Z; Sun J
    J Med Chem; 2021 Nov; 64(21):15936-15948. PubMed ID: 34723524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug Release from Disulfide-Linked Prodrugs: Role of Thiol Agents.
    Lei J; Zhang Q; Jin X; Lu H; Wang S; Li T; Sheng Y; Zhang F; Zheng Y
    Mol Pharm; 2021 Jul; 18(7):2777-2785. PubMed ID: 34121410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pH-responsive prodrug delivery system of 10-HCPT for controlled release and tumor targeting.
    Liu Y; Li D; Guo X; Xu H; Li Z; Zhang Y; Song C; Fan R; Tang X; Zhang Z
    Int J Nanomedicine; 2017; 12():2227-2242. PubMed ID: 28356739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Precisely albumin-hitchhiking tumor cell-activated reduction/oxidation-responsive docetaxel prodrugs for the hyperselective treatment of breast cancer.
    Wei W; Luo C; Yang J; Sun B; Zhao D; Liu Y; Wang Y; Yang W; Kan Q; Sun J; He Z
    J Control Release; 2018 Sep; 285():187-199. PubMed ID: 30017721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disulfide Bond-Based SN38 Prodrug Nanoassemblies with High Drug Loading and Reduction-Triggered Drug Release for Pancreatic Cancer Therapy.
    Zhong ZX; Li XZ; Liu JT; Qin N; Duan HQ; Duan XC
    Int J Nanomedicine; 2023; 18():1281-1298. PubMed ID: 36945256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy.
    Wang Z; Wu H; Liu P; Zeng F; Wu S
    Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carboxylated paclitaxel prodrug nanofibers for enhanced chemotherapy.
    Lu S; Hao D; Xiang X; Pei Q; Xie Z
    J Control Release; 2023 Mar; 355():528-537. PubMed ID: 36787820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy.
    Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X
    Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced bioreduction-responsive diselenide-based dimeric prodrug nanoparticles for triple negative breast cancer therapy.
    He X; Zhang J; Li C; Zhang Y; Lu Y; Zhang Y; Liu L; Ruan C; Chen Q; Chen X; Guo Q; Sun T; Cheng J; Jiang C
    Theranostics; 2018; 8(18):4884-4897. PubMed ID: 30429875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fabrication of redox-responsive doxorubicin and paclitaxel prodrug nanoparticles with microfluidics for selective cancer therapy.
    Ma X; Özliseli E; Zhang Y; Pan G; Wang D; Zhang H
    Biomater Sci; 2019 Jan; 7(2):634-644. PubMed ID: 30534690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ROS-Activated homodimeric podophyllotoxin nanomedicine with self-accelerating drug release for efficient cancer eradication.
    Liang B; Zhou D
    Drug Deliv; 2021 Dec; 28(1):2361-2372. PubMed ID: 34747277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transformative Nanomedicine of an Amphiphilic Camptothecin Prodrug for Long Circulation and High Tumor Uptake in Cancer Therapy.
    Zhang F; Zhu G; Jacobson O; Liu Y; Chen K; Yu G; Ni Q; Fan J; Yang Z; Xu F; Fu X; Wang Z; Ma Y; Niu G; Zhao X; Chen X
    ACS Nano; 2017 Sep; 11(9):8838-8848. PubMed ID: 28858467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
    Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
    Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.